John F Ward

10PUBLICATIONS
77CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targetsPredictive and prognostic markersMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 25, 2025
High-Dose Chemotherapy for Multiply or Poor-Risk Relapsed Germ Cell Tumors.

Yago Nieto, John F Ward, Wayne Hofstetter

|May 13, 2025
Bilateral Germ Cell Tumor of the Testis: Biological and Clinical Implications for a Stem Versus Genetic Origin of Cancers.

Jamaal C Jackson, Darren Sanchez, Aron Y Joon

|Jun 27, 2024
Germ Cell Tumor of the Testis: Lethal Subtypes of a Curable Cancer.

Jamaal C Jackson, Darren Sanchez, Andrew C Johns

|Jun 05, 2024
A phase II trial of apalutamide for intermediate-risk prostate cancer and molecular correlates.

Andrew W Hahn, Ganiraju C Manyam, Brian F Chapin

|Mar 15, 2024
Integrative Molecular Analyses of the MD Anderson Prostate Cancer Patient-derived Xenograft (MDA PCa PDX) Series.

Nicolas Anselmino, Estefania Labanca, Peter D A Shepherd

|Feb 10, 2024
A Novel Polymer-Encapsulated Multi-Imaging Modality Fiducial Marker with Positive Signal Contrast for Image-Guided Radiation Therapy.

Li Wang, Jeremiah Sanders, John F Ward

Pageof 2

Frequent Collaborators

3 joint publications

Louis Pisters

3 joint publications

Matthew T Campbell

2 joint publications

Jose A Karam

2 joint publications

John C Araujo